Oramed Pharmaceuticals
ORMP
ORMP
31 hedge funds and large institutions have $1.97M invested in Oramed Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
14% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 7
39% less capital invested
Capital invested by funds: $3.21M → $1.97M (-$1.25M)
Holders
31
Holding in Top 10
–
Calls
$583K
Puts
$550K
Top Buyers
| 1 | +$219K | |
| 2 | +$119K | |
| 3 | +$113K | |
| 4 |
Millennium Management
New York
|
+$40K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$23.4K |
Top Sellers
| 1 | -$196K | |
| 2 | -$120K | |
| 3 | -$110K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$70K |
| 5 |
Morgan Stanley
New York
|
-$49.4K |